Risperidone for the Treatment of Huntington's Disease Involuntary Movements

NCT04201834 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Huntington Disease
Chorea

Interventions

DRUG: Risperidone
DEVICE: BioStamp nPoint device

Sponsor

University of Rochester